Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OxyTec Medical was a medical technology company specializing in the development of portable oxygen concentration technology for patients with chronic respiratory conditions. Founded by the prolific inventor Dr. Robert Fischell and his family, the company aimed to replace cumbersome oxygen tanks with lightweight, battery-powered devices that extract oxygen from the air. Its flagship product, the Oxy-Gen, utilized advanced pressure swing adsorption (PSA) technology to provide a continuous and reliable source of medical-grade oxygen. This innovation was designed to significantly enhance the mobility and quality of life for individuals suffering from Chronic Obstructive Pulmonary Disease (COPD) and other forms of respiratory failure. In 2004, OxyTec Medical was acquired by Inogen, a leader in the portable oxygen market, which integrated OxyTec's intellectual property into its own product lines. The acquisition was a strategic move that helped solidify Inogen's position in the respiratory care industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OxyTec Medical.